Holen Sie sich die Stockscreener-App
8.98
5.60%
-0.533
Handel nachbörslich:
8.44
-0.54
-6.01%
Schlusskurs vom Vortag:
$9.513
Offen:
$9.5
24-Stunden-Volumen:
17,958
Relative Volume:
0.00
Marktkapitalisierung:
$5.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.42M
KGV:
-4.8804
EPS:
-1.84
Netto-Cashflow:
$-13.41M
1W Leistung:
-14.15%
1M Leistung:
-14.72%
6M Leistung:
+860.43%
1J Leistung:
+329.67%
1-Tages-Spanne:
$8.0001
$9.50
1-Wochen-Bereich:
$8.0001
$10.57
52-Wochen-Spanne:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Firmenname
Indaptus Therapeutics Inc
Sektor
Branche
Telefon
(646) 427-2727
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Vergleichen Sie INDP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
8.98 | 5.45M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Will Indaptus Therapeutics Inc. stock recover after recent dropFree Real Profit Trade Plan Suggestions - Newser
What makes Indaptus Therapeutics Inc. stock price move sharplyFree Community Verified Stock Suggestions - Newser
Using Bollinger Bands to evaluate Indaptus Therapeutics Inc.Multi-Year Signal Summary and Entry Timing - Newser
Why Indaptus Therapeutics Inc. stock attracts strong analyst attentionShort Term Setup With Predictive Chart Confirmed - beatles.ru
Is Indaptus Therapeutics Inc. in Accumulation Phase NowConsistent Profit Pattern Recognition Tools Shared - metal.it
Is Indaptus Therapeutics Inc. stock a growth or value playPortfolio Positioning Strategy With Timing - Newser
Indaptus Therapeutics Secures Approval for Private Placement - TipRanks
Is Indaptus Therapeutics Inc. stock a good hedge against inflationAccurate Forecast System with AI Support - Newser
Published on: 2025-07-29 21:05:39 - metal.it
How volatile are INDP's quarterly expenses? - AInvest
How Efficient Is Indaptus Therapeutics Inc. at Controlling Operating CostsFree Trade Insight With Community Collaboration - Newser
How many analysts rate Indaptus Therapeutics Inc. as a “Buy”Stock Strategy Entry Points Backed By Experts - jammulinksnews.com
Why is Indaptus Therapeutics Inc. stock attracting strong analyst attentionUnlock exclusive stock market forecasts - jammulinksnews.com
How does Indaptus Therapeutics Inc. compare to its industry peersMassive portfolio appreciation - jammulinksnews.com
How strong is Indaptus Therapeutics Inc. company’s balance sheetFree Investment Case Studies - jammulinksnews.com
Published on: 2025-07-28 05:00:38 - jammulinksnews.com
What institutional investors are buying Indaptus Therapeutics Inc. stockAchieve impressive returns with smart timing - jammulinksnews.com
What are Indaptus Therapeutics Inc. company’s key revenue driversMaximize gains with expert trading strategies - jammulinksnews.com
How high can Indaptus Therapeutics Inc. stock price go in 2025High Reward Swing Trades - Newser
Indaptus Therapeutics Inc. Stock Support and Resistance Levels You Should KnowTrend Following Trades - Newser
What analysts say about Indaptus Therapeutics Inc. stockDynamic capital growth - PrintWeekIndia
Is Indaptus Therapeutics Inc. a good long term investmentConsistent triple returns - Autocar Professional
Should I buy Indaptus Therapeutics Inc. stock before earningsAccelerated wealth building - jammulinksnews.com
Will Indaptus Therapeutics Inc. stock split in the near futureExceptional market performance - jammulinksnews.com
Indaptus Therapeutics Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - jammulinksnews.com
What drives Indaptus Therapeutics Inc. stock priceAccelerated profit realization - jammulinksnews.com
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):